Tracer library / [188Re]Re-6D2

[188Re]Re-6D2

Also written as [188Re]Re-6D2
Radionuclide
Re-188
Modality
—
Production route
—
Stage
Clinical research
Syntheses indexed
0
MelanomaOther radioligand therapy

What it is

Compound class
Monoclonal antibody (IgM) radioimmunoconjugate
Target / mechanism
Melanin (melanin-binding antibody 6D2) PMID 18535406
Clinical application
Metastatic melanoma PMID 18535406
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [188Re]Re-6D2, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 18535406, 19293257. Stage set/updated at stage 39 from PMID 18535406: 'made possible currently an on-going Phase I clinical trial in patients with metastatic melanoma'.